Your browser doesn't support javascript.
loading
The Penicillin Allergy Delabeling Program: A Multicenter Whole-of-Hospital Health Services Intervention and Comparative Effectiveness Study.
Chua, Kyra Y L; Vogrin, Sara; Bury, Susan; Douglas, Abby; Holmes, Natasha E; Tan, Nixon; Brusco, Natasha K; Hall, Rebecca; Lambros, Belinda; Lean, Jacinta; Stevenson, Wendy; Devchand, Misha; Garrett, Kent; Thursky, Karin; Grayson, M Lindsay; Slavin, Monica A; Phillips, Elizabeth J; Trubiano, Jason A.
Afiliación
  • Chua KYL; Department of Infectious Diseases and Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Australia.
  • Vogrin S; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Australia.
  • Bury S; Department of Infectious Diseases and Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Australia.
  • Douglas A; Department of Pharmacy, Austin Health, Heidelberg, Australia.
  • Holmes NE; Department of Infectious Diseases and the National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia.
  • Tan N; Department of Infectious Diseases and Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Australia.
  • Brusco NK; Department of Infectious Diseases and Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Australia.
  • Hall R; Alpha Crucis Group, Health Economics, Langwarrin, Australia.
  • Lambros B; Rehabilitation, Ageing and Independent Living Research Centre, Monash University, Frankston, Australia.
  • Lean J; Department of Infectious Diseases and Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Australia.
  • Stevenson W; Department of Infectious Diseases and the National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia.
  • Devchand M; Department of Infectious Diseases and the National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia.
  • Garrett K; Department of Infectious Diseases and Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Australia.
  • Thursky K; Department of Infectious Diseases and Centre for Antibiotic Allergy and Research, Austin Health, Heidelberg, Australia.
  • Grayson ML; Department of Pharmacy, Austin Health, Heidelberg, Australia.
  • Slavin MA; Department of Pharmacy, Austin Health, Heidelberg, Australia.
  • Phillips EJ; Department of Infectious Diseases and the National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Australia.
  • Trubiano JA; National Centre for Antimicrobial Stewardship, Royal Melbourne Hospital, Melbourne, Australia.
Clin Infect Dis ; 73(3): 487-496, 2021 08 02.
Article en En | MEDLINE | ID: mdl-32756983
ABSTRACT

BACKGROUND:

Penicillin allergies are associated with inferior patient and antimicrobial stewardship outcomes. We implemented a whole-of-hospital program to assess the efficacy of inpatient delabeling for low-risk penicillin allergies in hospitalized inpatients.

METHODS:

Patients ≥ 18 years of age with a low-risk penicillin allergy were offered a single-dose oral penicillin challenge or direct label removal based on history (direct delabeling). The primary endpoint was the proportion of patients delabeled. Key secondary endpoints were antibiotic utilization pre- (index admission) and post-delabeling (index admission and 90 days).

RESULTS:

Between 21 January 2019 and 31 August 2019, we assessed 1791 patients reporting 2315 antibiotic allergies, 1225 with a penicillin allergy. Three hundred fifty-five patients were delabeled 161 by direct delabeling and 194 via oral penicillin challenge. Ninety-seven percent (194/200) of patients were negative upon oral penicillin challenge. In the delabeled patients, we observed an increase in narrow-spectrum penicillin usage (adjusted odds ratio [OR], 10.51 [95% confidence interval {CI}, 5.39-20.48]), improved appropriate antibiotic prescribing (adjusted OR, 2.13 [95% CI, 1.45-3.13]), and a reduction in restricted antibiotic usage (adjusted OR, 0.38 [95% CI, .27-.54]). In the propensity score analysis, there was an increase in narrow-spectrum penicillins (OR, 10.89 [95% CI, 5.09-23.31]) and ß-lactam/ß-lactamase inhibitors (OR, 6.68 [95% CI, 3.94-11.35]) and a reduction in restricted antibiotic use (OR, 0.52 [95% CI, .36-.74]) and inappropriate prescriptions (relative risk ratio, 0.43 [95% CI, .26-.72]) in the delabeled group compared with the group who retained their allergy label.

CONCLUSIONS:

This health services program using a combination of direct delabeling and oral penicillin challenge resulted in significant impacts on the use of preferred antibiotics and appropriate prescribing.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hipersensibilidad a las Drogas / Programas de Optimización del Uso de los Antimicrobianos Tipo de estudio: Clinical_trials / Etiology_studies / Evaluation_studies Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hipersensibilidad a las Drogas / Programas de Optimización del Uso de los Antimicrobianos Tipo de estudio: Clinical_trials / Etiology_studies / Evaluation_studies Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Australia